Corbus Pharmaceuticals (CRBP) P/E (2014 - 2026)
Corbus Pharmaceuticals (CRBP) P/E from Nov 11, 2014 to Jul 21, 2026. The TTM Corbus Pharmaceuticals (CRBP) P/E is -1.56. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Corbus Pharmaceuticals (CRBP)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.56 | +12.10% |
| 2025 | -1.39 | -59.49% |
| 2024 | -3.43 | +528.88% |
| 2023 | -0.55 | +64.61% |
| 2022 | -0.33 | -80.34% |
| 2021 | -1.69 | +119.71% |
| 2020 | -0.77 | -85.97% |
| 2019 | -5.47 | -8.78% |
| 2018 | -5.99 | -49.08% |
| 2017 | -11.77 | -49.70% |
| 2016 | -23.40 | +281.61% |
| 2015 | -6.13 | -84.78% |
| 2014 | -40.28 | N/A |
Comparison Corbus Pharmaceuticals (CRBP) P/E with competitors
Corbus Pharmaceuticals (CRBP) P/E is -1.56.